NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.5700
+0.0200 (3.64%)
May 1, 2026, 9:44 AM EST
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 50.63 million as of May 1, 2026. Its market cap has increased by 1.47% in one year.
Market Cap
50.63M
Enterprise Value
47.84M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.57
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 50.63M, an increase of 51.20%. That is a compound annual growth rate of 11.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 50.63M | -15.41% |
| Dec 31, 2025 | 59.85M | 36.16% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ME Therapeutics Holdings | 75.12M |
| Sharp Therapeutics | 63.16M |
| Sernova Biotherapeutics | 61.45M |
| Medicenna Therapeutics | 47.55M |
| Quantum BioPharma | 43.14M |
| BriaCell Therapeutics | 40.02M |
| Defence Therapeutics | 39.31M |
| MedMira | 38.60M |